KRISTINA CARPENTER: Open Payments
NPI 1952741985 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 11 payments from 10 companies in 2025. Trend: 2023 $79 · 2024 $183 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $31 |
| Lundbeck LLC | 1 | $28 |
| Exact Sciences Corporation | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Indivior Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $6 |
Products named: VRAYLAR, HETLIOZ, Wegovy, REXULTI, Cologuard Collection Kit, FARXIGA, SUBLOCADE, XIFAXAN.
Industry payments across CA — which companies pay providers there.
